On October 1, 2025 Circio Holding ASA (OSE: CRNA), a biotechnology company developing powerful circular RNA technology for next generation nucleic acid medicine, reported that the European Society of Cell and Gene Therapy (ESGCT) has selected a Circio abstract for poster presentation at its annual meeting 2025 (Press release, Circio, OCT 1, 2025, https://www.circio.com/en/circio-to-present-comprehensive-circvec-aav-in-vivo-data-package-at-esgct-2025/ [SID1234656375]). The presentation will detail how Circio is enhancing gene and cell therapy using circVec, its circular RNA vector expression technology. Specifically, Circio will summarize recent in vivo results demonstrating significant advantages of its circVec-AAV platform over conventional AAVs in heart and other tissues.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"Circio´s most recent in vivo results continue to demonstrate circVec´s strong potential as a novel expression system for enhanced gene and cell therapy. The prestigious ESGCT annual meeting provides an excellent opportunity for us to showcase our latest pre-clinical data to a wide industry and academic audience," said Dr. Thomas B. Hansen, CTO of Circio. "At this year´s conference, we will present the major advances we have made to enhance conventional AAV gene therapy using the circVec platform, showing statistically significant increases in expression in multiple tissues for several circVec-AAV variants."
Title of presentation:
CircVec: Enhancing gene and cell therapy using circular RNA vector expression technology (poster no. 1041)
Presenter:
CTO Dr. Thomas B Hansen & CSO Dr. Victor Levitsky
Time:
14:00hrs CEST, 8 October 2025
Location:
Fibes, Seville, Spain